| LHEG | local healthcare executive group |
|---|---|
| TEAM | techniques for effective alcohol management; Training in Expanded Auxiliary Management; transfemoral... |
| HFMA | Healthcare Financial Management Association |
| HIMSS | Healthcare Information and Management Systems Society |
| CEO | chick embryo origin; Chief Executive Officer |
| LISS | Low ionic strength solutions |
|---|---|
| ACHS | Australian Council of Healthcare Standards |
| JCAHO | Joint Commission of Accreditation of Healthcare Organizations |
| CEO | Chief Executive Officer |
| HSE | Health and Safety Executive |
| chief executive officers, hospital | Individuals who have the formal authority to manage a hospital, including its programs and services, in accordance with the goals and objectives established by a governing body (governing board). (12 Dec 1998) |
|---|---|
| joint commission on accreditation of healthcare organizations | A private, voluntary, not-for-profit organization which establishes standards for the operation of health facilities and services, conducts surveys, and awards accreditation. (12 Dec 1998) |
| cardioplegic solutions | Solutions which, upon administration, will temporarily arrest cardiac activity. They are used in the performance of heart surgery. (12 Dec 1998) |
| rehydration solutions | Fluids restored to the body in order to maintain normal water-electrolyte balance. (12 Dec 1998) |
| pharmaceutical solutions | Homogeneous liquid preparations that contain one or more chemical substances dissolved, i.e., molecularly dispersed, in a suitable solvent or mixture of mutually miscible solvents. For reasons of their ingredients, method of preparation, or use, they do not fall into another group of products. (12 Dec 1998) |
| contact lens solutions | Sterile solutions used to clean and disinfect contact lenses. (12 Dec 1998) |
| haemodialysis solutions | Solutions prepared for haemodialysis. The composition of the pre-dialysis solution may be varied in order to determine the effect of solvated metabolites on anoxia, malnutrition, acid-base balance, etc. Of principal interest are the effect of the choice of buffers (e.g., acetate or carbonate), the addition of cations (na+, k+, calcium), and addition of carbohydrates (glucose). (12 Dec 1998) |
| sclerosing solutions | Chemical agents injected into veins to cause localised thrombosis and eventual fibrosis and obliteration of the vessels. They are used in the treatment of varicose veins, haemorrhoids, gastric and oesophageal varices, and peptic ulcer haemorrhage. (12 Dec 1998) |
| hypertonic solutions | Solutions having a higher osmotic pressure than blood, or another solution with which they are compared. (12 Dec 1998) |
| hypotonic solutions | Solutions having a lower osmotic pressure than blood, or another solution with which they are compared. (12 Dec 1998) |
| solutions | The homogeneous mixtures formed by the mixing of a solid, liquid, or gaseous substance (solute) with a liquid (the solvent), from which the dissolved substances can be recovered by physical processes. (12 Dec 1998) |
| dialysis solutions | Solutions prepared for exchange across a semipermeable membrane of solutes below a molecular size determined by the cutoff threshold of the membrane material. (12 Dec 1998) |
| isotonic solutions | Solutions having the same osmotic pressure as blood serum, or another solution with which they are compared. (12 Dec 1998) |
| ophthalmic solutions | Sterile solutions, essentially free from foreign particles and suitably compounded and dispensed, for instillation into the eye. It does not include solutions for cleaning eyeglasses or contact lens solutions. (12 Dec 1998) |
| organ preservation solutions | Solutions used to store organs, particulary those awaiting implantation. (12 Dec 1998) |
제품명 |
판매사 |
보험코드 | 성분/함량 | 구분/보험급여 |
|---|
제품명 |
판매사 |
보험코드 | 성분/함량 | 구분/보험급여 |
|---|